Healthy subjects were assigned to seven BMS-820836 dose panels ( 0.025 , 0.1 , 0.5 , 1 , 2 , 3 , and 5 mg ; n = 8 each ) , in which subjects were randomly allocated 3:1 to a single BMS-820836 dose or matched placebo .